Research, News & Discoveries

Catherine Leasure, PhD’23, has been awarded the prestigious ASPIRE to Innovate Postdoctoral Fellowship. In her new role, which began on July 1, 2023, she is focusing on forming a start-up company based on technology developed at Vanderbilt University by Gregor Neuert, associate professor of molecular physiology and biophysics, that can model the pharmacodynamic profile of drugs. Read More

The latest scientific research from Basic Sciences faculty and trainees. Read More

Hang out with Nashville’s brain scientists at Brain Blast 2024. Open to students in grades K–8 and their families, the event will take place Saturday, March 23, at the downtown Nashville Public Library. Read More

Bruce Carter, Lisa Monteggia, Richard O’Brien, Andrea Page-McCaw, and Kevin Schey have been named endowed chairs, the highest academic award that Vanderbilt can give to a faculty member. Read More

The team prompted the chatbot to review the biomedical research literature and suggest 20 drugs for Alzheimer’s disease, ranking them for potential effectiveness. With a second prompt they asked for confirmation of the initial 20 suggestions. They repeated both prompts 10 times. Read More

ASPIRE to Innovate Postdoctoral Fellow Catherine Leasure identifies the issues plaguing drug development. Leasure and Gregor Neuert argue that conventional dose-response studies fail to mirror the complex reality of how drugs behave in the human body. Read More

The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read More

Led by Terunaga Nakagawa, an international collaboration describes for the first time the fundamental mechanism underpinning cellular processes that lead to learning and memory. Read More

A research endeavor that seeks to develop a new cancer immunotherapy utilizing nanobody delivery and targeted heating of tumors has received funding from the Waddell Walker Hancock Cancer Discovery Fund. Read More

The lab of Professor of Biochemistry Fred Guengerich has proposed a paradigm shift in the understanding of a critical chemical reaction involved in sterol biosynthesis. Read More